How to Take a Liver-Focused History

Most patients with liver disease do not present with a liver complaint. They present with fatigue, an abnormal lab, or an incidental imaging finding. Establish what brought them in, then trace the timeline of symptoms and prior testing. Key symptoms to ask about regardless of scenario: jaundice or scleral icterus, abdominal distension, fatigue, pruritus, dark urine, pale or clay-colored stools, right upper quadrant discomfort, confusion or personality change, and any history of hematemesis or melena.

Identify conditions that are either a cause of liver disease or that complicate its management. The metabolic syndrome cluster — type 2 diabetes, obesity, hypertension, and hypertriglyceridemia — is the most common background for metabolic dysfunction-associated steatotic liver disease (MASLD), now the most prevalent liver disease in the US. Also ask about prior liver-related diagnoses, hospitalizations, and whether the patient has had imaging of their abdomen before.

Abdominal surgical history is directly relevant in hepatology. Prior procedures can be a clue to etiology, alter management options, and are critical information for transplant evaluation. Always ask about biliary procedures specifically, as cholecystectomy and biliary reconstructions are often not volunteered.

Drug-induced liver injury (DILI) is underrecognized because patients do not volunteer supplement use, and providers do not always ask. You must ask explicitly and by category. Acetaminophen is the most common cause of acute liver failure in the United States — always quantify total daily dose across all products (cold medicines, PM formulations, prescription combination drugs). Herbal and dietary supplements (green tea extract, kava, pyrrolizidine alkaloids, anabolic supplements) are an increasingly important cause of DILI and require specific questioning. Consult LiverTox for any agent you're unsure about.

Social history in hepatology is unusually high-yield. Alcohol use, substance use, and infectious exposures — all covered here — are the dominant etiologic drivers of liver disease. Ask without judgment and explain why you're asking. Patients are more forthcoming when they understand the clinical reason for the question. Also establish baseline social support, since patients with cirrhosis in particular require significant support networks for medication adherence, procedure logistics, and transplant eligibility.

Alcohol

Asking "do you drink?" is insufficient. You need quantity, frequency, duration, and pattern. Use standardized tools where appropriate:

• AUDIT-C (Alcohol Use Disorders Identification Test — Concise): Three-question screen for hazardous or harmful alcohol use. A score ≥3 in women or ≥4 in men warrants further assessment.
• CAGE (Cut down, Annoyed, Guilty, Eye-opener): Each "yes" answer scores 1 point. A score ≥2 is a positive screen and warrants further evaluation for alcohol use disorder.
• Quantify in standard drinks per week. In the US, one standard drink contains 14g of pure ethanol — note that this definition varies by country (e.g., 10g in the UK, 10g in Australia, 8g in Sweden). Common US examples: 12 oz of regular beer (~5% ABV), 5 oz of wine (~12% ABV), or 1.5 oz of distilled spirits (~40% ABV). Heavy use: >7 drinks/week in women, >14 drinks/week in men.
• Ask about pattern: daily drinking vs. binge drinking carry different risks and prognostic implications.
• Establish timeline: duration of heavy use correlates with fibrosis burden.

Substance Use & Infectious Exposures

Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain leading causes of cirrhosis and hepatocellular carcinoma (HCC) globally. Exposures are primarily behavioral and geographic — and require a targeted history:

• Birth country: HBV is endemic in sub-Saharan Africa and Southeast and East Asia; vertical transmission is the dominant route.
• HCV screening: The CDC recommends at least one lifetime HCV screening test for all adults ≥18 years, regardless of risk factors. Those with ongoing risk behaviors should be screened periodically.
• IV drug use, past or present, even a single episode (HCV, HBV)
• High-risk sexual behavior, history of sexually transmitted infections (STIs) (HBV)
• Blood transfusion prior to 1992 (HCV screening was not yet universal)
• Healthcare worker exposures, tattoos, piercings in unregulated settings
• Cocaine use (direct hepatotoxin), anabolic steroid use

Hereditary liver diseases are underdiagnosed, often because they are not asked about. Hemochromatosis (HFE mutations) is the most common genetic liver disease in people of Northern European ancestry and is frequently missed for years. Wilson's disease and alpha-1 antitrypsin deficiency should be considered in younger patients. A family history of autoimmune conditions raises the prior probability of autoimmune hepatitis, primary biliary cholangitis (PBC), or PSC.

The ROS in hepatology serves two functions: identifying symptoms that suggest advanced or decompensated disease, and uncovering findings that point toward specific etiologies. A targeted organ-system sweep should cover the gastrointestinal, integumentary, neurological, and constitutional domains at minimum.